Cancer Drug Combos: US FDA Guidance Offers Options Beyond Factorial Trials

 
• By Manas Mishra
  
Human Connecting Two Pieces Of Puzzle
The guidance adds to 2013 regulations focused on experimental drug combinations. (Shutterstock)

More from Real-World Evidence

More from Pathways & Standards